These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 35872836)

  • 1. Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant.
    Xu S; Yao X; Li B; Cui R; Zhu C; Wang Y; Yang W
    Front Pharmacol; 2021; 12():740996. PubMed ID: 35872836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of ketamine action as an antidepressant.
    Zanos P; Gould TD
    Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.
    Yang C; Kobayashi S; Nakao K; Dong C; Han M; Qu Y; Ren Q; Zhang JC; Ma M; Toki H; Yamaguchi JI; Chaki S; Shirayama Y; Nakazawa K; Manabe T; Hashimoto K
    Biol Psychiatry; 2018 Oct; 84(8):591-600. PubMed ID: 29945718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
    Miller OH; Moran JT; Hall BJ
    Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
    Hara H; Suzuki A; Kunugi A; Tajima Y; Yamada R; Kimura H
    Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
    Koike H; Fukumoto K; Iijima M; Chaki S
    Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of eEF2 kinase in the rapid antidepressant actions of ketamine.
    Suzuki K; Monteggia LM
    Adv Pharmacol; 2020; 89():79-99. PubMed ID: 32616215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms.
    Wei IH; Chen KT; Tsai MH; Wu CH; Lane HY; Huang CC
    J Agric Food Chem; 2017 Dec; 65(49):10792-10803. PubMed ID: 29161812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2
    Fukumoto K; Fogaça MV; Liu RJ; Duman C; Kato T; Li XY; Duman RS
    Proc Natl Acad Sci U S A; 2019 Jan; 116(1):297-302. PubMed ID: 30559184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites.
    Yang C; Yang J; Luo A; Hashimoto K
    Transl Psychiatry; 2019 Nov; 9(1):280. PubMed ID: 31699965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergent Mechanisms Underlying Rapid Antidepressant Action.
    Zanos P; Thompson SM; Duman RS; Zarate CA; Gould TD
    CNS Drugs; 2018 Mar; 32(3):197-227. PubMed ID: 29516301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxynorketamine: Implications for the NMDA Receptor Hypothesis of Ketamine's Antidepressant Action.
    Aleksandrova LR; Wang YT; Phillips AG
    Chronic Stress (Thousand Oaks); 2017; 1():. PubMed ID: 30556028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses.
    Gideons ES; Kavalali ET; Monteggia LM
    Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8649-54. PubMed ID: 24912158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review.
    Iadarola ND; Niciu MJ; Richards EM; Vande Voort JL; Ballard ED; Lundin NB; Nugent AC; Machado-Vieira R; Zarate CA
    Ther Adv Chronic Dis; 2015 May; 6(3):97-114. PubMed ID: 25954495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
    du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies.
    Pham TH; Gardier AM
    Pharmacol Ther; 2019 Jul; 199():58-90. PubMed ID: 30851296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.
    Shen M; Lv D; Liu X; Li S; Chen Y; Zhang Y; Wang Z; Wang C
    Brain Res Bull; 2018 Oct; 143():58-65. PubMed ID: 30316917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant-like effect of ginsenoside Rb1 on potentiating synaptic plasticity via the miR-134-mediated BDNF signaling pathway in a mouse model of chronic stress-induced depression.
    Wang G; An T; Lei C; Zhu X; Yang L; Zhang L; Zhang R
    J Ginseng Res; 2022 May; 46(3):376-386. PubMed ID: 35600767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the mTOR signaling pathway in the rapid antidepressant action of ketamine.
    Hashimoto K
    Expert Rev Neurother; 2011 Jan; 11(1):33-6. PubMed ID: 21158553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
    Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
    J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.